Clinical trial

OMT-111 for Terminal Stage Solid Tumors

NCT04520386

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-10-01

PhasePHASE2

Study timeline

Study start (estimated)2020-10-01Date precision: month

Registry last updated2020-09-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Pancreatic Cancerunresolved

Lung Cancerunresolved

Interventions

OMT-111DRUG

Sponsors & collaborators

MetiMedi Pharmaceuticalslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04520386 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.